A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Dhivya, L. S.
- Protective role of Borreria hispida against Galactosamine Induced Diabetic Cataract
Authors
1 Dept of Pharmacology, SRM College of Pharmacy, Kasttankulathur, Kancheepuram District, Tamilnadu, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 3 (2019), Pagination: 1235-1238Abstract
Cataract is the major cause of blindness all over the world, nearly 42% of visual impairment occurs due to diabetic associated complications in the eye. Borreria hispida, belonging to Rubiaceae family was used to treat eye infections by folklore system of medicine in India. This study was aimed to create scientific evidence for the anti-cataract activity of hydroalcoholic leaf extract of Borreria hispida (HAEBH) in diabetes induced cataract using goat lens. Cataract was induced using galactosamine in goat eyes lens. In this study, isolated goat lenses were suspended in bovine serum albumin. Totally sixteen lenses were selected, each group containing four lenses - normal control (distilled water treated lens), galactosamine treated lens, 1mg/ml of the hydroalcoholic extract of Borreria hispida leaves extract treated lens (HAEBH) and finally 1mg/ml of standard drug atropine treated lens. The opacification of lens were monitored in all the sixteen lenses. Among these, the anticataract activity of Borreria hispida was strengthened by the reduction in the deposition of proteins which is involved in the opacification of lens compared to galactosamine treated lens. The extract shown effective anticataract effect similar to that of standard group. The hydroalcoholic extract of Borreria hispida possess anticataract activity may be due to inhibition of Aldose Reductase enzyme involved in the polyol pathway which has a prime role in developing diabetes induced cataract. Further studies has to be carried out to isolate the prominent biomolecule responsible to control diabetes associated cataract.Keywords
Borreria hispida, Galactosamine, Aldose Reductase, Polyol Pathway.References
- D.K. Patel, S.K. Prasad, R Kumar, S Hemalatha . Asia Pac J Trop Disease, (2011); 323-9.
- Deepak G Langade, G Rao, RC Girme, PS Patki, PM Bulakh In vitro prevention by ACE inhibitors of cataract induced by glucose. Indian J of Pharmacol. 2006 :8(2): 107-110
- Eye Diseases Prevalence Research Group Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. (2004;)122:487–494.
- GV Sampath Kumar, VVL Sri Vidya, Ch. Sandhya. Hepatoprotective Activity of Borreria hispida Roots Against Carbon Tetrachloride induced hepatotoxicity in Albino Wister Rats. Int J of Bio and Pharm Res (2013); 4(12) 1277-1282
- R Dhevi, V. Elango. Invitro Antioxidant activity and HPTLC Fringer printing of seeds of Spermacoce hispida linn. IJPPR (2015); 7-3-23a, 7-3-23b, 7-3-23c.
- K Chandrashekhar, Vinayak Meti., Shishir Mishra. Pharmacological Activities of Spermacoce hispidalinn: A review, IJRAP 4(1), Jan- Feb 2013.
- Farnsworth NR 1988. Screening plants for new medicines. In: Biodiversity, EO Wilson and FM Peter (eds), National Aca Press, Washington D.C., pp. 83—97.
- A G Chandorkar , M V Albal, PM Bulakh , MP Muley . Lens Organ Culture. Indian Journal of Ophthalmology,1981: 29(3): PP 151-152
- Lowry, A. Rosebrough, A. Farr , R. Randall J Biol Chem, 1951; 193:265 13. Srikanth Merugu , B Veeresh , Deepa Rekulapally . T Swetha. Study Of In Vitro Anticataract Activity Of Tamarindus indica Linn On Isolated Goat Lenses. Int Jl of Pharm (2012); 2(4) 758-763.
- Srikanth Merugu, B. Veeresh , Deepa Rekulapally . T Swetha. Study Of In Vitro Anticataract Activity of Tamarindus indica Linn On Isolated Goat Lenses. Int J of Phar 1951; 193:265 13.
- Lowry OH, Rosebrough NJ, Farr LA, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275.
- P. Thenmozhi., T.V. Poonguzhali., B. Janarthanam. Phytochemical Screening And Antioxidant Activity Of Borreria hispida L.- An anticancer plant. Int J of Modern Trends in Eng and Res: 2016:3(2): PP
- Khan SS, Chaghtai SA, Oommachan M. Medicinal plants of Rubiaceae of Bhopal - An Ethnobotanical study. J Scient Res (Bhopal) 1984; 6:37–9.
- Purushothaman KK, Kalyani K. Isolation of isorhamnetin from Borreria hispida Linn. J Res Indian Med Yoga Homeop. 1979; 14:131–2.
- Kaviarasan K, Kalaiarasi P, Pugalendi V. Antioxidant efficacy of flavonoid-rich fraction from Spermacoce hispida in hyperlipidemic rats. J Appl Biomed. 2008;6: 165–76.
- J. H. Kinoshita. A thirty year journey in the polyol pathway, Exp. Eye Res. 50 (1990); 567–573.
- Computational Investigation of Plant-based Bioactive Compounds as Inhibitors against Tuberculosis
Authors
1 Dr. APJ Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Kancheepuram, Tamil Nadu, IN
2 Department of Pharmacognosy and Phytochemistry, Parul Institute of Pharmacy and Research, Parul University, Vadodara – 391760, Gujarat, IN
3 Dr. APJ Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Kancheepuram, Tamil Nadu Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur – 603203, Kancheepuram, Tamil Nadu, IN
Source
Journal of Natural Remedies, Vol 22, No 3 (2022), Pagination: 457 - 471Abstract
The objective of the work is to identify a natural origin compound that could have an anti-tubercular effect, thereby preventing the infection in humans using computational approach. Our focus was to find a inhibitor for Enoyl- acyl carrier reductase enzyme and hence chemically diverse scaffolds from plants origin were selected. Admet parameters were performed for the compounds, and the top nine compounds among 50 compounds were found to be non-carcinogenic. The pharmacological predicted activity (Pa) of few compounds such as 14-Deoxy-11,12 didehydroandrographolide, Terflavin B, and Liquirtin was found to be more active when compared with that of the standard reference. Further more the synthesis of these active compounds derivatives can be investigated theoretical followed by its synthesis and evaluation by in vitro activity against the InhA could be of interest.
Keywords
InhA, Liquirtin, Mycobacterium tuberculosis, Molecular Docking, Terflavin B.References
- Zaman K. Tuberculosis: A global health problem. J Health Popul Nutr. 2010; 28(2):111–3. https://doi.org/10.3329/ jhpn.v28i2.4879. PMid:20411672. PMCid:PMC2980871
- Chandir S, Hussain H, Salahuddin N, Amir M, Ali F, Lotia I, et al. Extrapulmonary tuberculosis: A retrospective review of 194 cases at a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc. 2010; 60(2):105–9. PMID: 20209695.
- Sandhu GK. Tuberculosis: Current situation, challenges and overview of its control programs in India. J Glob Infect Dis. 2011; 3(2):143–50. https://doi.org/10.4103/0974- 777X.81691. PMid:21731301. PMCid:PMC3125027
- Chadha VK. Progress towards millennium development goals for TB control in seven Asian countries. Indian J Tuberc. 2009; 56(1):30–43.PMID: 19402270.
- Smith KC, Armitige L, Wanger A. A review of tuberculo- sis: Reflections on the past, present and future of a global epidemic disease. Expert Rev Anti Infect Ther. 2003; 1(3):483–91. https://doi.org/10.1586/14787210.1.3.483. PMid:15482144
- Singh MM. XDR-TB--danger ahead. Indian J Tuberc. 2007; 54(1):1–2. PMID: 17455416.
- Gupta R, Thakur B, Singh P, Singh HB, Sharma VD, Katoch VM, et al. Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuber- culosis isolates. Indian J Med Res. 2010; 131:809–13.PMID: 20571171.
- Houben RM, Dodd PJ. The global burden of latent tuber- culosis infection: A re-estimation using mathematical modelling. PLoS Medicine. 2016; 13(10). https://doi. org/10.1371/journal.pmed.1002152. PMid:27780211. PMCid:PMC5079585
- Suresh AJ, Nandini S, Sangeetha K, Dhivya LS, Surya PR. Design, synthesis and invitro biological evaluation of pyridine, thiadazole, benzimidazole and acetyl thiophne analogues as anti tubercular agents targeting enzyme InhA. Curr Comput-Aided. 2020. https://doi.org/10.2174/157340 9916666200724152827. PMid:32713342
- Suresh J, Baek SC, Ramakrishnan SP, Kim H, Mathew B. Discovery of potent and reversible MAO-B inhibi- tors as furanochalcones. Int J Biol Macromol. 2018; 108:660–4. https://doi.org/10.1016/j.ijbiomac.2017.11.159. PMid:29195801
- Sander T, Freyss J, von Korff M, Reich JR, Rufener C. OSIRIS, an entirely in-house developed drug discovery informatics system. J Chem Inf Model. 2009; 49(2):232–46. https://doi.org/10.1021/ci800305f. PMid:19434825
- Sabarathinam S, Vijayakumar TM. Assessment of herb- drug interactions based on the pharmacokinetic changes of probe drug, midazolam. Drug Metab Lett. 2021; 14(1):5–8. https://doi.org/10.2174/1872312814666201112122110. PMid:33183217
- Sabarathinam S, Vijayakumar TM. A short exploration of selected sensitive CYP3A4 substrates (probe drug). Drug Metab Lett. 2021; 14(1):2–4. https://doi.org/10.2174/18723 12814666200811110024. PMid:32781977
- Mittal M, Goel RK, Bhargava G, Mahajan MP. PASS-assisted exploration of antidepressant activity of 1,3,4-trisubsti- tuted-beta-lactam derivatives. Bioorganic Med Chem Lett. 2008; 18(20):5347–9. https://doi.org/10.1016/j. bmcl.2008.09.064. PMid:18835165
- Tucker EW, Dooley KE. Preclinical tools for the evalua- tion of tuberculosis treatment regimens for children. Int J Tuberc Lung Dis. 2018; 22(5):7–14. https://doi.org/10.5588/ ijtld.17.0354. PMid:29665948. PMCid: PMC7577428
- Maiolini M, Gause S, Taylor J, Steakin T, Shipp G, Lamichhane P, et al. The war against tuberculosis: A review of natural compounds and their derivatives. Molecules (Basel, Switzerland). 2020; 25(13). https://doi.org/10.3390/ molecules25133011. PMid:32630150. PMCid:PMC7412169
- Aanouz I, Belhassan A, El-Khatabi K, Lakhlifi T, El-Ldrissi M, Bouachrine M. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. J Biomol Struct Dyn. 2021; 39(8):2971-9. https:// doi.org/10.1080/07391102.2020.1758790. PMid:32306860. PMCid:PMC7212546
- Gutierrez-Lugo MT, Bewley CA. Natural products, small molecules, and genetics in tuberculosis drug development. J Med Chem. 2008; 51(9):2606–12. https://doi.org/10.1021/ jm070719i. PMid:18393405. PMCid:PMC6260804
- Borad MA, Jethava DJ, Bhoi MN, Patel CN, Pandya HA, Patel HD. Novel isoniazid-spirooxindole derivatives: design, synthesis, biological evaluation, in silico ADMET predic- tion and computational studies. J Mol Struct. 2020; 1222. https://doi.org/10.1016/j.molstruc.2020.128881
- Guan L, Yang H, Cai Y, Sun L, Di P, Li W, et al. ADMET- score - a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2018; 10(1):148– 57. https://doi.org/10.1039/C8MD00472B. PMid:30774861. PMCid:PMC6350845